Explore the best tesamorelin stack options, including CJC-1295, ipamorelin, and AOD-9604, plus dosage considerations, safety, and legal status.
There is no single best tesamorelin stack. The right choice depends on the user’s medical goal, legal status, and clinical supervision, and the most discussed options pair tesamorelin with a growth hormone–releasing peptide (GHRP) like ipamorelin or a longer-acting GHRH like CJC-1295. Tesamorelin is FDA-approved only for HIV-associated lipodystrophy, not for general fat loss or athletic performance.
How Tesamorelin Stacks Work
Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It tells the pituitary gland to release growth hormone. Stacking means adding another peptide that acts on a different part of that same pathway.
The goal of a tesamorelin peptide stack is usually to amplify or extend the natural growth hormone pulse. Some users add a GHRP to increase pulse frequency, while others add a fat-metabolism peptide such as AOD-9604. When people search for the best stack with tesamorelin, they are usually comparing GHRH analogs, GHRPs, and metabolic peptides.
No stack containing tesamorelin is FDA-approved for general weight loss or bodybuilding.
Most Discussed Tesamorelin Stack Options
Tesamorelin + CJC-1295 or Ipamorelin
A common research combination is the cjc 1295 ipamorelin tesamorelin stack, which pairs a GHRH analog with a GHRP. CJC-1295 may extend the growth hormone pulse, while ipamorelin may increase pulse amplitude. These combinations are not FDA-approved for human use, and human data on stacking tesamorelin with CJC-1295 or ipamorelin are very limited.
Tesamorelin + Sermorelin
Sermorelin is another GHRH analog, but it has a shorter half-life than tesamorelin. A tesamorelin and sermorelin stack is sometimes discussed online, yet combining two GHRH analogs is usually redundant because they act on the same receptor. No clinical trials support this combination for any indication.
Tesamorelin + AOD-9604 or MOTS-c
AOD-9604 is a fragment of human growth hormone that is studied for fat metabolism. Some users combine it with tesamorelin in a tesamorelin aod-9604 stack. MOTS-c is a mitochondrial peptide, and an aod-9604 mots-c tesamorelin stack is occasionally mentioned in research forums.
AOD-9604 and MOTS-c are not FDA-approved for human use in the United States. Human safety data for combining them with tesamorelin are lacking.
| Stack | Primary Rationale | FDA Status |
|---|---|---|
| Tesamorelin + CJC-1295 | Longer growth hormone pulse | CJC-1295 not approved |
| Tesamorelin + Ipamorelin | GHRH plus GHRP for pulse amplitude | Ipamorelin not approved |
| Tesamorelin + Sermorelin | Two GHRH analogs on the same receptor | Sermorelin not approved |
| Tesamorelin + AOD-9604 | Add a fat-metabolism peptide | AOD-9604 not approved |
| Tesamorelin + MOTS-c | Add a mitochondrial peptide | MOTS-c not approved |
| Tesamorelin alone | FDA-approved for HIV-associated lipodystrophy | Prescription only |
Dosage and Timing Considerations
The FDA-approved dose of tesamorelin is 2 mg injected subcutaneously once daily for HIV-associated lipodystrophy. There is no approved dose for any tesamorelin stack. Online discussions of an aod-9604 tesamorelin stack dosage often list numbers that have not been validated in clinical trials.
Dosage and timing for unapproved peptides vary widely by source. The table below summarizes what is known about approved dosing versus stack dosing.
| Component | Approved Dose (If Any) | Stack Dose Status |
|---|---|---|
| Tesamorelin | 2 mg SC once daily for HIV-associated lipodystrophy | No approved stack dose |
| CJC-1295 | Not FDA-approved | No standard dose |
| Ipamorelin | Not FDA-approved | No standard dose |
| Sermorelin | Not FDA-approved | No standard dose |
| AOD-9604 | Not FDA-approved | No standard dose |
| MOTS-c | Not FDA-approved | No standard dose |
Anyone considering a tesamorelin stack should get dosing guidance from a licensed healthcare provider, not from an online vendor.
Safety, Side Effects, and Legal Status
Tesamorelin can cause injection-site reactions, muscle pain, joint pain, and changes in blood sugar. It can also raise IGF-1 levels, which requires monitoring in clinical use.
- Tesamorelin is a prescription drug in the United States. It is approved only for HIV-associated lipodystrophy, a condition involving abnormal fat distribution.
- CJC-1295, ipamorelin, sermorelin, AOD-9604, and MOTS-c are not FDA-approved for human use. They are sold as research chemicals, and their safety profiles are not established.
- Combining unapproved peptides with a prescription drug increases unknown risks. Interactions, immune reactions, and long-term effects have not been studied.
- Tesamorelin is not a cosmetic weight-loss drug. Stacking it with other peptides does not change its approved indication.
How to Evaluate a Tesamorelin Stack
- Define the medical goal with a licensed clinician before considering any peptide.
- Check the FDA approval status of every component. Most peptides in popular stacks are not approved.
- Look for peer-reviewed human data, not forum anecdotes or vendor testimonials.
- Avoid sources that sell peptides without a prescription or medical oversight.
- If a clinician prescribes tesamorelin, follow their monitoring plan for blood sugar, IGF-1, and side effects.
The best tesamorelin stack is the one that is legally prescribed, medically supervised, and supported by human data.
Bottom Line
There is no universally best tesamorelin stack. Tesamorelin is FDA-approved only for HIV-associated lipodystrophy, and the peptides commonly stacked with it are not approved for human use. Online rankings of tesamorelin peptide stacks should not replace medical advice.
No tesamorelin stack is FDA-approved for general fat loss or athletic performance. If you have a medical condition that tesamorelin treats, talk to a healthcare provider about whether it is appropriate for you.
Frequently Asked Questions
What is the best stack with tesamorelin?
There is no universally best stack with tesamorelin. The most discussed combinations pair tesamorelin with CJC-1295, ipamorelin, or AOD-9604, but none of those combinations are FDA-approved. Tesamorelin itself is only FDA-approved for HIV-associated lipodystrophy.
Is tesamorelin safe to stack with ipamorelin?
Ipamorelin is not FDA-approved for human use, so safety data for combining it with tesamorelin are limited. Tesamorelin can cause injection-site reactions, joint pain, and blood sugar changes. Anyone considering this combination should talk to a licensed healthcare provider.
How much tesamorelin do you take in a stack?
The FDA-approved dose of tesamorelin is 2 mg injected subcutaneously once daily for HIV-associated lipodystrophy. There is no approved dose for stacking tesamorelin with other peptides. Online dosage claims are not validated by clinical trials.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.